Glutaminase 1 (GLS1) facilitates the conversion of glutamine to glutamate, and co-treatment with the GLS1 inhibitor CB-839 and the glutamine transporter inhibitor V-9302 induced apoptosis in mouse liver cancer cells and suppressed HCC xenografts (116). Here, GLS is linked to liver cancer.